Literature DB >> 16493191

QT PRODACT: inter-facility variability in electrocardiographic and hemodynamic parameters in conscious dogs and monkeys.

Hiroyuki Sasaki1, Noritsugu Shimizu, Hideki Suganami, Keiji Yamamoto.   

Abstract

In safety pharmacology studies, the effect of a test compound on the electrocardiogram is routinely examined by using conscious dogs. However, the results may be widely variable. The monkey, on the other hand, has scarcely been used for such studies; and as yet, there have not been reported studies on monkeys conducted at several facilities with a standard protocol. In the present study, we examined inter-facility variabilities in electrocardiographic and hemodynamic parameters as described below. We analyzed the data from 8 facilities (9 test groups) on dogs and 5 facilities (7 test groups) on monkeys. This data was obtained from the studies employing the following standard protocol: dl-Sotalol or a vehicle (0.5 w/v% methylcellulose solution) was given to animals; and the PR interval, QRS duration, QT interval, heart rate, and mean blood pressure were determined time-sequentially before and after administration of the vehicle or dl-sotalol in each test group. dl-Sotalol produced a prolongation of the maximum mean QTcF interval in conscious dogs and QTcB interval in conscious monkeys by more than 10% in every test group. No difference in the corrected QT interval among the test groups was observed in dogs, but a difference was observed in monkeys.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16493191     DOI: 10.1254/jphs.qt-b6

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  6 in total

Review 1.  Principles of safety pharmacology.

Authors:  M K Pugsley; S Authier; M J Curtis
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739

2.  Inter-study variability of preclinical in vivo safety studies and translational exposure-QTc relationships--a PKPD meta-analysis.

Authors:  V Gotta; F Cools; K van Ammel; D J Gallacher; S A G Visser; F Sannajust; P Morissette; M Danhof; P H van der Graaf
Journal:  Br J Pharmacol       Date:  2015-07-21       Impact factor: 8.739

3.  International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug-induced torsades de pointes.

Authors:  A S Bass; B Darpo; A Breidenbach; K Bruse; H S Feldman; D Garnes; T Hammond; W Haverkamp; C January; J Koerner; C Lawrence; D Leishman; D Roden; J P Valentin; M A Vos; Y-Y Zhou; T Karluss; P Sager
Journal:  Br J Pharmacol       Date:  2008-08       Impact factor: 8.739

4.  Dose-response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeys.

Authors:  J J Lynch; A W Wilson; L E Hernandez; R A Nelson; K C Marsh; B F Cox; S W Mittelstadt
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

5.  Detection of QTc interval prolongation using jacket telemetry in conscious non-human primates: comparison with implanted telemetry.

Authors:  K Derakhchan; R W Chui; D Stevens; W Gu; H M Vargas
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

6.  Can non-clinical repolarization assays predict the results of clinical thorough QT studies? Results from a research consortium.

Authors:  Eunjung Park; Gary A Gintant; Daoqin Bi; Devi Kozeli; Syril D Pettit; Jennifer B Pierson; Matthew Skinner; James Willard; Todd Wisialowski; John Koerner; Jean-Pierre Valentin
Journal:  Br J Pharmacol       Date:  2018-01-15       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.